133 related articles for article (PubMed ID: 21791112)
1. Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients.
He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
J Exp Clin Cancer Res; 2011 Jul; 30(1):70. PubMed ID: 21791112
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of FAT10 is correlated with progression and prognosis of human glioma.
Yuan J; Tu Y; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
Pathol Oncol Res; 2012 Oct; 18(4):833-9. PubMed ID: 22402871
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients.
Sun B; Chu D; Li W; Chu X; Li Y; Wei D; Li H
J Neurooncol; 2009 Sep; 94(2):213-9. PubMed ID: 19337694
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
Xu Y; Yuan J; Zhang Z; Lin L; Xu S
Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of N-methylpurine-DNA glycosylase influences patient survival in malignant gliomas.
Liu C; Tu Y; Yuan J; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
J Biomed Biotechnol; 2012; 2012():760679. PubMed ID: 22496614
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.
Li W; Chu D; Chu X; Meng F; Wei D; Li H; Sun B
J Clin Neurosci; 2011 Nov; 18(11):1534-7. PubMed ID: 21872476
[TBL] [Abstract][Full Text] [Related]
8. Expression of HAUSP in gliomas correlates with disease progression and survival of patients.
Cheng C; Niu C; Yang Y; Wang Y; Lu M
Oncol Rep; 2013 May; 29(5):1730-6. PubMed ID: 23483195
[TBL] [Abstract][Full Text] [Related]
9. CD24 expression as a marker for predicting clinical outcome in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
J Biomed Biotechnol; 2012; 2012():517172. PubMed ID: 22500096
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
12. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
13. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
[TBL] [Abstract][Full Text] [Related]
14. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
15. Increased argonaute 2 expression in gliomas and its association with tumor progression and poor prognosis.
Feng B; Hu P; Lu SJ; Chen JB; Ge RL
Asian Pac J Cancer Prev; 2014; 15(9):4079-83. PubMed ID: 24935600
[TBL] [Abstract][Full Text] [Related]
16. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.
Wang L; Yuan J; Tu Y; Mao X; He S; Fu G; Zong J; Zhang Y
Clin Transl Oncol; 2013 Feb; 15(2):139-45. PubMed ID: 22855183
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
Men D; Liang Y; Chen L
Cancer Epidemiol; 2014 Apr; 38(2):152-6. PubMed ID: 24559637
[TBL] [Abstract][Full Text] [Related]
20. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
